Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook - 2023

Int J Surg. 2023 Apr 1;109(4):658-659. doi: 10.1097/JS9.0000000000000258.

Shopnil Akash¹, Md Shajib Khan¹, Nobendu Mukerjee^{2

3}, Shabana Bibi^{4

5}

¹ Department of Pharmacy, Faculty of Allied Health Science, Daffodil International University, Daffodil Smart City, Ashulia, Savar, Dhaka, Bangladesh.
² Department of Microbiology, West Bengal State University, Kolkata, West Bengal, India.
³ Department of Health Sciences, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
⁴ Department of Biosciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
⁵ Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming, China.

No abstract available

Publication types